Opioids in chronic pain management: Is there a significant risk of addiction?
Tóm tắt
Từ khóa
Tài liệu tham khảo
Snyder CA: An open letter to physicians who have patients with chronic nonmalignant pain. J Law Med Ethics 1994, 22:204–205.
Katz J, Kavanagh BP, Sandler AN, et al.: Pre-emptive analgesia: clinical evidence of neuroplasticity contributing to postoperative pain. Anesthesiology 1992, 77:439–446.
Richmond CE, Bromley LM, Woolf CJ: Preoperative morphine preempts postoperative pain. Lancet 1993, 342:73–75.
Collins R, Brandner B, Bromley LM, Woolf CJ: Is there any clinical advantage of increasing the preemptive dose of morphine or combining pre-incisional with postoperative morphine administration? Br J Anaesth 1995, 74:396–399.
Zech DFJ, Grong S, Lynch J, et al.: Validation of the World Health Organization guidelines for cancer pain relief: a 10 year prospective study. Pain 1996, 63:65–76.
Patt RB, Burton AW: Pain associated with advanced malignancy, including adjuvant analgesic drugs in cancer pain management. In Evaluation & Treatment of Chronic Pain, edn 3. Edited by Aronoff GM. Baltimore: Williams & Wilkins; 1999:337–376.
Portenoy RK: Opioid therapy for chronic nonmalignant pain: a review of the critical issues. Special section on opioids for nonmalignant pain. Part 1. J Pain Symptom Manage 1996, 11:203–217. Detailed discussion on the use of opioids with high-risk patients. Reviews clinical issues as well as barriers to adequate pain care.
Von Roenn JH, Cleeland CS, Gonin R, et al.: Physicians attitudes and practice in cancer pain management. Ann Intern Med 1993, 119:121–126.
Cleeland CS, Gonin R, Hatfield AK, et al.: Pain and its treatment in out-patients with metastatic cancer. N Engl J Med 1994, 330:592–596.
Ferrell BR, Cohen MZ, Rhiner M, Rozek A: Pain as a metaphor for illness. Part 1: family caregivers’ management of pain. Oncol Nurs Forum 1991, 18:1315–1321.
McCaffery M, Ferrell BR: Correcting misconceptions about pain assessment and use of opioid analgesics: educational strategies aimed at public concerns. Nurs Outlook 1996, 44:184–190.
Jacox A, Carr DB, Payne R, et al.: Management of Cancer Pain: Adults Quick Reference Guide. No. 9. Rockville, MD: Agency for Health Care Policy and Research, Public Health Service, U.S. Department of Health and Human Services; 1994. AHCPR publication no. 94-0593.
Acute Pain Management Guideline Panel: In Acute Pain Management in Adults: Operative Procedures. Quick Reference Guide for Clinicians. Rockville, MD: Agency for Health Care Policy and Research, Public Health Service, U.S. Department of Health and Human Services; 1992. AHCPR publication no 92-0019.
Haddox JD, Joranson D, Angarola RT, et al.: The use of opioids for the treatment of chronic pain. A consensus statement from the American Academy of Pain Medicine and the American Pain Society. Clin J Pain 1997, 13:6–8.
Joranson DE, Cleeland CS, Weissman DE, Gilson AM: Opioids for chronic cancer and non-cancer pain: a survey of state medical board members. Fed Bull 1992, 4:15–49.
Arkinstall W, Sandler A, Babel N, et al.: Efficacy of controlledrelease codeine in chronic non-malignant pain: a randomized, placebo-controlled clinical trial. Pain 1995, 62:169–178.
Moulin DE, Iezzi A, Amireh R, et al.: Randomized trial of oral morphine for chronic non-cancer pain. Lancet 1996, 347:143–147.
Taub A: Opioid analgesics in the treatment of chronic intractable pain of non-neoplastic origin. In Narcotic Analgesics in Anesthesiology. Edited by Kitahata LM, Collins D. Baltimore: Williams & Wilkins; 1982:199–208.
Brookoff D, Palomano R: Treating sickle cell pain like cancer pain. Ann Intern Med 1992, 116:364–368.
France RD, Urban BJ, Keefe FJ: Long-term use of narcotic analgesics in chronic pain. Soc Sci Med 1984, 19:1379–1382.
Green J, Coyle M: Methadone use in the control of nonmalignant chronic pain. Pain Manage 1989, Sept/Oct:241–246.
Kell MJ, Musselman DL: Methadone prophylaxis of intractable headache pain control and serum opioid levels. AJPM 1993, 3:7–14.
Portenoy RK, Foley KM: Chronic use of opioid analgesics in non-malignant pain: report of 38 cases. Pain 1986, 25:171–186.
Tennant FS, Uelman GF: Narcotic maintenance for chronic pain: medical and legal guidelines. Postgrad Med 1983, 73:81–94.
Tennant FS, Robinson D, Sagherian A, Seecof R: Chronic opioid treatment of intractable non-malignant pain. Pain Manage 1988, Jan/Feb:18–36.
Urban BJ, France RD, Steinberger DL, et al.: Long-term use of narcotic antidepressant medication in the management of phantom limb pain. Pain 1986, 24:191–197.
Zenz M, Strumpf M, Tryba M: Long-term opioid therapy in patients with chronic non-malignant pain. J Pain Symptom Manage 1992, 7:69–77.
Buckley FP, Sizemore WA, Charlton JE: Medication management in patients with chronic nonmalignant pain: a review of the use of a drug withdrawal protocol. Pain 1986, 26:153–166.
Finlayson RD, Maruta T, Morse BR: Substance dependence and chronic pain: profile of 50 patients treated in an alcohol and drug dependence unit. Pain 1986, 26:167–174.
Finlayson RD, Maruta T, Morse BR, Martin MA: Substance dependence and chronic pain: experience with treatment and follow-up results. Pain 1986, 26:175–180.
Maruta T, Swanson DW: Problems with the use of oxycodone compounds in patients with chronic pain. Pain 1981, 11:389–396.
Maruta T, Swanson DW, Finlayson RE: Drug abuse and dependency in patients with chronic pain. Mayo Clinic Proc 1979, 54:241–244.
McNairy SL, Maruta T, Ivnak RJ, et al.: Prescription medication dependence and neuropsychologic function. Pain 1984, 18:169–177.
Ready LB, Sarkis E, Turner JA: Self-reported vs. actual use of medications in chronic pain patients. Pain 1982, 12:285–294.
Turner JA, Calsyn DA, Fordyce WE, Ready LB: Drug utilization pattern in chronic pain patients. Pain 1982, 12:357–363.
Aronoff GM, Wagner JM, Spangler AS Jr: Chemical interventions for pain. J Consult Clin Psychol 1986, 54:769–775.
World Health Organization: Cancer Pain Relief. Geneva: WHO; 1986.
Aronoff GM: Evaluation and Treatment of Chronic Pain, edn 3. Edited by Aronoff GM. Baltimore: Williams & Wilkins; 1999: 433–453.
Jaffe J: Opiates: clinical aspects. In Substance Abuse: A Comprehensive Textbook, edn 2. Edited by Lowinson J et al. Baltimore: Williams and Wilkins; 1992:186–194.
Portenoy RK, Payne R: Acute and chronic pain. In Substance Abuse: A Comprehensive Textbook, edn 2. Edited by Lowinson JH et al. Baltimore: Williams and Wilkins; 1992:691–721.
Twycross RG, Lack SA: Symptom Control in Far Advanced Cancer: Pain Relief. London: Pitman Books; 1983.
Twycross RG: Clinical experience with diamorphine in advanced malignant disease. Int J Clin Pharmacol Ther Toxicol 1974, 9:184–198.
Kanner RM, Foley KM: Patterns of narcotic drug use in a cancer pain clinic. Ann N Y Acad Sci 1981, 362:161–172.
Gourlay GK, Cherry DA, Cousins MJ: A comparative study of the efficacy and pharmacokinetics of oral methadone and morphine in the treatment of severe pain in patients with cancer. Pain 1986, 25:297–312.
Portenoy RK, Foley KM, Inturrisi CE: The nature of opioid responsiveness and its implications for neuropathic pain: new hypotheses derived from studies of opioid infusions. Pain 1990, 43:273–286.
Aronoff GM: Pain centers: treatment for intractable suffering and disability resulting from chronic pain. In Evaluation and Treatment of Chronic Pain, edn 3. Edited by Aronoff GM. Baltimore: Williams and Wilkins; 1999:591–603.
Zacny JP: A review of the effects of opioids on psychomotor and cognitive functioning in humans. Exp Clin Psychopharmacol 1995, 3:432–466.
Starmer GA: A review of the effects of analgesics on driving performance. In Drugs and Driving. Edited by O’Hanlon JF, deGier JJ. London: Taylor & Francis; 1986:251–269.
Chesher GB: Understanding the opioid analgesics and their effects on skills performance. Alcohol Drugs Driving 1989, 5:111–138.
Hanks GW, O’Neill WM, Simpson P, et al.: The cognitive and psychomotor effects of opioid analgesics. II. A randomized controlled trial of single doses of morphine, lorazepam and placebo in healthy subjects. Eur J Clin Pharmacol 1995, 48:455–460.
Vainio A, Ollila J, Matikainen E, et al.: Driving ability in cancer patients receiving long-term morphine analgesia. Lancet 1995, 346:667–670.
Kappes S, Laux G: Driving performance of opiate addicts under methadone supported rehabilitation. Pharmacopsychiatry 1995, 28:191.
Lodemann E, Leifer K, Kluwig J, et al.: Methadone maintenance and driving ability. Pharmacopsychiatry 1995, 28:199.
O’Neill WM, Hanks GW, McIntyre E, et al.: An investigation of the cognitive effects of repeated doses of opioid analgesics in volunteers. Eur J Clin Invest 1995, 25:379.
Shannon CN, Baranowski: Use of opioids in non-cancer pain. Brit J Hosp Med 1997, 58:9:459–462.
Savage SR: Long-term opioid therapy: assessment of consequences and risks. J Pain Symptom Manage 1996, 11:274–286.
Hoffman NG, Olofsson O, Salen B, Wickstrom L: Prevalence of abuse and dependency in chronic pain patients. Int J Addict 1995, 30:919–927.
Miotto K, Compton P, Ling W, Conolly M: Diagnosing addictive disease in chronic pain patients. Psychosomatics 1996, 37:223–235.
Aronoff GM: Psychodynamics and psychotherapy of the chronic pain patient. In Evaluation and Treatment of Chronic Pain, edn 3. Edited by Aronoff GM. Baltimore: Williams and Wilkins; 1999:283–290.
Aronoff GM: Psychiatric Aspects of Nonmalignant Chronic Pain: A New Nosology. In Evaluation and Treatment of Chronic Pain, edn 3. Edited by Aronoff GM. Baltimore: Williams and Wilkins; 1999:291–300.
Blumer D: Psychiatric considerations in pain. In Spine, vol 2. Edited by Rothman RH, Simeone FA. Philadelpia: Saunders; 1975.
Pilowski I, Spence ND: 69. Pilowski I, Spence ND: Psychodynamic aspects of the pain experience. In Psychology of Pain. Edited by Sternbach RA. New York: Raven Press; 1978.
Sifneos PE: The prevalence of “alexithymic” characteristics in psychosomatic patients. Psychother Psychosom 1973, 22:255–262.
Hackett TP: The chronic pain patient: evaluation and treatment in Massachusets General Hospital. In Handbook of General Hospital Psychiatry. Edited by Hackett TP, Cassem NH. St. Louis: Mosby; 1978.
American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, edn 3 revised. Washington: American Psychiatric Association; 1987.
American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, edn 4. Washington: American Psychiatric Association; 1994.
Ferrell BR, Griffith H: Cost issues related to pain management: report from the cancer pain panel of the agency for health care policy and research. J Pain Symptom Manage 1994, 9:221–234.
Ward SE, Gordon D: Application of the American Pain Society quality assurance standards. Pain 1994, 56:299–306.
Hill HE, Haertzen CA, Davis H: An MMPI factor analytic study of alcoholics, narcotic addicts and criminals. Q J Stud Alcohol 1962, 23:411–431.
Hill HE, Haertzen CA, Glaser R: Personality characteristics of narcotic addicts as indicated by the MMPI. J Gen Psychol 1960, 62:127–139.
Sawe J, Hansen J, Ginman C, et al.: A patient-controlled dose regimen of methadone in chronic cancer pain. Br Med J 1981, 282:771–773.
Blumer D, Heilbronn M: Chronic Pain as a variant of depressive disease: the pain-prone disorder. J Nerv Ment Dis 1982, 170:381–406.
Fishman SM, Bandman TB, Edwards A, Borsook D: The opioid contract in the management of chronic pain. J Pain Symptom Manage 1999, 18:27–37.
Haddox JD, Aronoff GM: Commentary: the potential for unintended consequences from public policy shifts in the treatment of pain. J Law Med Ethics 1998, 26:350–352. Will assist physicians in understanding factors shaping newer trends in opioids regulation and prescribing practices.
California Pain Patient’s Bill of Rights, California Health & Safety Code 1.